Medical Marijuana Projects
Matica and RoyalMax have completed a state of the art 10,000 sq. ft., cannabis growing facility in Dorval Quebec. It is fully completed and ready to receive growing materials upon granting of a cultivation licence by Health Canada.
The facility is fully climate controlled with automated plant nutrient systems to ensure the highest quality product. The facility is divided into several grow rooms to accommodate different strains. There is also a large vault for secure storage. The project was a retrofit of an existing building. The facility is located in an industrial park in Dorval, Quebec. Dorval is a mainly industrial suburb on the West Island of Montreal. The facility is near the Montreal−Pierre Elliot Trudeau International Airport and the Dorval Train Station. It is also very near highways 20, 520 and 13.
RoyalMax has submitted a Photographic-Evidence video package to Health Canada to request a cultivation license. To assist us in achieving our goals the Company has engaged the services of David Hyde & Associates Inc. to communicate with Health Canada on behalf of RoyalMax. David Hyde is one of Canada’s top independent security consultants, an industry-recognized leader and trusted senior advisor to many large organizations. Mr. Hyde and his team offer a full-service cannabis security licensing advisory service based in Toronto and operating across Canada.
Under the agreement with RoyalMax Biotechnology Canada Inc., Matica is to become a majority owner (70%) of a late stage applicant under the Access to Cannabis for Medical Purposes Regulation - ACMPR.
On a sprawling 181 acre farm property in Hemmingford, Quebec, the Company will construct approximately 200,000 square feet of cannabis specific greenhouses.
Hemmingford is beautiful rural community south of Montreal. Matica has chosen to build greenhouses on the South Shore, in an area known as “Les Jardins du Quebec” (Quebec’s gardens). This region receives a large amount of sunlight and is reported by Agriculture and Agri-Food Canada to receive over 1,800 effective growing degree days. The unique microclimate and access to fresh water makes this an excellent agricultural region within an hour’s drive of Montreal. This is an ideal location to establish large sections of greenhouses for growing cannabis.
It is Matica’s intention to build up to 1,000,000 square feet of combined greenhouses in additional phases. The property has ample water via creeks, ponds, and a well. There is also abundant power supply through 600 amp power lines that traverse the property which will support large greenhouse operations. Matica will be working with greenhouse designer Ron Berkhout, who has built greenhouses across Ontario.
In addition to a massive greenhouse project, this property has ample room for Matica to grow cannabis outdoors as well. With 50 acres of tillable land we will be able to devote a large section of land to producing cannabis. Outdoor growing can produce cannabis at a fraction of the cost of indoor grow rooms.
The Hemmingford farm will be a very exciting project with amazing potential.
Nova Scotia MMPR
In October 2014 Matica signed a definitive agreement to earn a fifty percent interest in THC Dispensaries Canada, Inc (“THCD”), a Nova Scotia applicant. In December 2015 Matica filed a Notice of Civil Claim in the Vancouver Registry of the Supreme Court of British Columbia in an effort to recoup funds and other damages suffered by Matica.
The Company has reached a settlement where unrelated third party has agreed to purchase all of the outstanding shares of THCD and complete the build out of THCD’s facility. THCD is one of several such facilities that the third party has engaged. Matica was to receive shares of the third party at a deemed value of $700,000 in two tranches of $350,000 each. Matica has now received full settlement and looks forward to the success of the project.
Other Marijuana Projects
Matica has made an investment in Yunify Natural Technologies, a Quebec based health and personal care research and innovation technology company.
Yunify is a Quebec based research and innovation company which creates personal care products and agricultural products. Yunify is a leader in sustainable, clean, and green chemistries. Its technologies can be found in various market segments including: skincare, cosmetics, nutraceuticals and food growing agricultural products for open fields and green houses. The company is based in St-Hubert on the south shore of Montreal.
Yunify is a green biotechnology leader in cannabinoid-based active ingredient and delivery systems. Its unique hydro-mineral technology platform allows for the replacement of petroleum based and undesirable chemistries with truly sustainable green ingredients. The company focuses on three core business pillars: consumer personal care and nutraceuticals, agriculture and greenhouse growth inputs and functional innovations in related industries through discovery licensing.
By teaming up with Yunify, Matica takes a leading role in new product development in the cannabis industry. The Company recognizes the acute need for alternative cannabis delivery systems, especially through pain relief topicals. Matica will directly benefit from research and be able to produce new revolutionary topical products within the cannabis space. Yunify will create proprietary topical products for Matica based on its proprietary mineral and plant based suspension technologies.
Matica will finance Yunify for $2,000,000.00. The first tranche of $600,000.00 was paid on closing of the transaction. A second tranche of $400,000.00 and the final tranche of $1,000,000 are due within the one year to maturity date. The debenture is convertible into units of Yunify at a $0.225 exercise price. Each unit is comprised of one common share, one-half common share purchase warrant of which one full warrant will entitle the holder to purchase one common share of the Company for a period of 36 months from the closing date at an exercise price of $0.35 per warrant, and one-half common share purchase warrant of which one full warrant will entitle the holder to purchase one common share of the Company for a period of 36 months from the closing date at an exercise price of $0.50 per warrant. By fully exercising the warrants, Matica may acquire a 40 per cent interest in Yunify.